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Non-technical Summary
At the European Council in Lisbon in March 2000, heads of state and governments set the European Union the ambitious goal of becoming "the most competitive and dynamic knowledge-based economy in the world by the end of the decade". Two years later the Council reaffirmed this goal in Barcelona and added it to a more specific but equally ambitious target of raising EU spending on research and development to 3% of GDP by 2010 -with two thirds of this spend by the business sector.
From the perspective of innovation, public R&D spending is an input factor which should strengthen the European Union's competitiveness in future technologies. In this context, the question arises, whether public R&D spending enlarges the welfare of societies. An analysis of such a question requires an identification of input-output relationships between publicly funded R&D activities and their results, like patent outcome or commercialized products and services as well as cost reducing processes. In this paper we investigate patent applications of firms. As the stimulation of R&D cooperations and networks has become very popular in technology policies of the EU, we focus our analysis especially on R&D collaborations at the firm level.
First, we describe the history of public R&D funding in Germany and the development of measures encouraging collaborative R&D activities among firms and public research institutions. Afterwards, we investigate empirically the impact of such measures on patenting activity at the firm level. The main issue of our analysis is to distinguish three different groups of firms: (i) non-collaborating companies, (ii) collaborating firms which are involved in publicly funded R&D consortia, (iii) firms with only privately financed R&D collaborations.
We use a sample of 4,132 observations on German firms from the 1990s and apply Probit estimations on the propensity to patent as well as a count data model on the number of granted patents. In a further step, we carry out a non-parametric kernel-based matching to take account of a possible self-selection bias in the sample of publicly funded firms. The microeconometric results show that collaborating firms are more likely to patent than non-collaborating firms. This points to the existence of knowledge flows which generate positive spillover effects among network partners. Within the group of collaborating firms, participants in publicly sponsored R&D consortia exhibit a higher probability to patent than firms in non-sponsored networks. Especially SMEs seem to benefit from spillovers which makes their application for patents more likely. A reason for this result might be determined by the official funding guidelines and the pressure of the granting institutions who force the participants to utilize their research results within a time period of two years after completion of the funded research projects.
Introduction
Governments in the world emphasize the need to improve the transfer of know-how throughout the innovation system. This means more collaboration between science and industry to strengthen the national innovation capabilities. In most OECD countries public measures are directed to bring private organizations and public research institutions closer together, providing researchers and projects with skills and incentives to take their ideas to the market (cf. OECD, 2002) . The main focus of cooperative R&D policies is to exchange expertise among performers, primarily between academic scientists and industrial researchers. Its main objective is to improve the economic contribution of scientists, to improve technological capabilities, and to support innovations and patent activities.
Today's governments search for effective compositions of technology policy instruments, such as fiscal measures, credits or subsidies which are most promising for future growth. "If technological innovation is called the most important force driving economic growth, then public policies designed to promote and encourage technological innovation take on substantial importance" (Branstetter/Sakakibara, 2002) . Recently, the European Commission has introduced large networks of excellence in the 6 th Framework Programme. Multipartner projects aimed at strengthening the excellence on a research topic by combining resources and expertise. "This expertise will be networked around a joint programme of activities aimed primarily at creating a progressive and lasting integration of the research activities of the network partners, while at the same time advancing knowledge on the topic" (European Commission, 2002) . In this line, research and innovation policies have recognised that publicly funded collaborations and R&D networks are promising to strengthen the national competitiveness. Following these discoveries, traditional instruments to stimulate private and public R&D activities have been enlarged by new modes, such as contests and research networks which are characterised by a large number of partners.
Germany was one of the first countries in Europe which offered intensive co-operative R&D funding in the early 1980s and which introduced co-operative network competitions for public funding in the 1990s. This study tries to shed some light on the reasonable question on the return on that investment:
What are the benefits of public incentives for R&D collaborations in terms of innovative output?
In the following section we summarize theoretical and empirical evidence on networks, alliances and partnerships in the innovation process. In section 3, we give an overview on the development and the status-quo of publicly funded R&D co-operations in Germany. Section 4 deals with a microeconometric study on the research productivity (measured by patents) of German firms. The main issue of our analysis is to distinguish the patenting behavior of three different groups of firms: (i) non-collaborating companies, (ii) collaborating firms which are involved in publicly funded R&D consortia, (iii) firms with only privately financed R&D collaborations. We study whether R&D collaborations lead to higher research output. This would support the hypothesis that knowledge flows among partners emerge and positive spillovers are generated. Moreover, we investigate if publicly funded firm collaborations differ from collaborations which are privately financed.
Theory and empirical perspectives on R&D collaborations
The question how and why firms engage in collaborations, partnerships, alliances, joint ventures and networks emerged during the 1980s in economic literature. Different theories and empirical studies have analyzed the mechanisms within research consortia and their benefits. Important contributions have been provided by Katz (1986) , d 'Aspremont/Jacquemin (1988 ), Freeman (1991 , Kamien et al. (1992) , Katsoulacos/Ulph (1998) , Robertson/Gatignon (1998) , Kamien/Zang (2000) and recently by Branstetter/Sakakibara (2002) . Hagedoorn et al. (2000) present a literature review in which they do not only surveyed studies on research partnerships but also take technology policy issues into account.
More recently, Link et al. (2002) give an overview of strategic research partnerships, taking public financial support to firms into account. In Europe, especially in Germany, Austria and France, we actually observe large efforts of R&D policies to link industry-science relationships for a sustainable output in innovation. Huge amounts of government funds are offered to stimulate co-operation in regional and technological R&D networks. The objective of these European policy activities is to improve competitiveness and to overcome obstacles of growth and unemployment.
Publicly funded R&D co-operations are sponsored to stimulate R&D pacts, because in an intensive technological competition a high-performance research system seems to be a necessary precondition for economic success. In the last decade, we observe an increase of the knowledge intensity in production, in market and technological uncertainties, as well as trends towards specialization in combination with growing technological complexity. Moreover, some kinds of knowledge such as tacit or embedded knowledge can not or just hardly be acquired by market transactions. In times of globalization, the emerging of new media, and of growing research challenges, high-tech competition increasingly requires joint efforts to carry out R&D. Co-operations have obvious advantages, like positive spillovers as well as cost and risk sharing (cf. Audretsch, 2003) . Cassiman/Veugelers (2002) explore in an empirical study the effects of knowledge flows on R&D co-operation. Their results suggest that firms with higher incoming spillovers and better appropriation have a higher probability of co-operating in R&D. In the face of these results the question remains, why firms enter R&D networks and if collaborating firms are successful in terms of innovation productivity? Hagedoorn et al. (2000) identify three broad categories of explanation why firms enter into research partnerships: (a) transaction cost theory, (b) strategic management theory and (c) industrial organization theory. In transaction cost theory, R&D co-operations are explained as a hybrid form of organization between the market and the hierarchy to facilitate an activity specifically related to the production and dissemination of technological knowledge. Due to the lacking appropriability of R&D, positive external effects are generated. In order to internalize such effects, companies prefer to engage in research collaborations with possible third party users of their research results. In the strategic management theory, research partnerships are explained by a competitive reasons (common defensive position against competitors), by strategic networks (economies of scale and scope), by a resource based view of the firm (to exploit unique capabilities), by dynamic capabilities (to combine competencies) and by strategic options to new technologies (to determine resources for superior future performance). In the industrial organization theory, research collaborations are explained by the existence of market failures due to the perceived public good nature of knowledge. The majority of theoretical studies deal with imperfect appropriable R&D and an increase of market power. Bayona et al. (2001) review similar reasons to explain co-operation: (i) the reduction and sharing of uncertainty and costs, (ii) motivations relating to market access and the search for opportunities, (iii) size and R&D capacity as characteristics of the firms.
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The increasing globalization imposes high requirements on the innovativeness of all industrialized countries. This changing environment requires flexible adjustment strategies -not only on part of the business sector. Since the mid 1980s several governments stimulate developments that lead to intensified collaboration among existing organizations. Famous industry-science partnership programs have been designed to enhance the competitiveness of science and industry in the USA (SBIR, ATP, SEMATECH), in Japan (VLSI) and in Europe (ESPRIT, EURECA, CRAFT). In addition most
European countries offer national funding schemes to attract R&D collaborations. Especially small and medium sized enterprises (SMEs) often cannot afford in-house R&D. This is where publicly funded research co-operation schemes take effect. Support is provided for firms and public research institutions which jointly implement a research project. Governments stimulate collaborations because R&D consortia are expected to realize spillovers which are seen most important for cost reduction and a higher productivity.
Recent empirical studies have established that contractual forms of R&D, such as joint R&D has become a very important mode of inter-firm and science-firm collaboration as the number of partnerships has largely increased (Sakakibara, 1997; Hagedoorn/Narula, 1996 ) Sakakibara, 2001 analyzed Japanese Government-sponsored R&D consortia over 13 years and has found evidence that the diversity of a consortium is associated with greater R&D expenditure by participating firms. The results support the thesis that spillover effects occur. The magnitude of the effect of the participation in an R&D consortium on firm R&D expenditures is found to be nine percent, on average.
1 Further theoretical arguments to questions related to research partnerships and well-known scientific representatives are surveyed and/or listed by Vonortas (1997) , Hagedoorn et al. (2000) , de la Mothe/ . Branstetter/Sakakibara (2002) examine the impact of government-sponsored research consortia on the research productivity in Japan by measuring their patenting activities over time. They find evidence that participants of research consortia tend to increase their patenting after entering a consortium, which is interpreted as evidence for spillovers. The marginal increase of participants' patenting in targeted technologies, relatively to the control firms, is large and statistically significant. Lerner (1999) and Audretsch et al. (2002) evaluate public support of private sector R&D using a broad statisticalbased analysis and case-study based investigations of SBIR recipients in the USA. Lerner (1999) supposed that knowledge spillovers cause particularly large differentials between the private and social benefits from SBIR because spillovers to other firms may be more frequent if applicants involve very early-stage technologies. Audretsch et al. (2002) At the beginning of the 1980s, researchers and policy makers have realized that innovative and successful companies rely on alliances, SMEs as subcontractors and intensive co-operations with academics. The success and the exploitation of R&D projects was expected to be more efficient if many partners were involved and for that reason governments were thinking about best practices to stimulate R&D co-operations. Japan was the most popular example of public efforts to foster R&D cooperation, because its hardware industry succeeded in the "Very Large Integration Project" (VLSI) towards the US world market leadership IBM. The success of this project was attributed to temporary alliances of big companies, SMEs, universities and public laboratories. R&D activities of all project partners were financed in a cost sharing between public authorities and private organizations. The first imitator of this R&D collaboration strategy was the USA, which followed with the well known converted from monopolistic sciences carried out in large multinationals into a broadly used multipurpose technology. In these times, Government was afraid that an ongoing individual R&D funding may result in similar market distortions as suspected by public sector critics in other funding areas.
Because of a huge number of new technology firms which aligned their R&D activities in these technology fields, R&D policymakers reacted immediately and preferred collaborative research projects, too (cf. Fier, 2002) .
In the mid nineties, Germany has opened a further chapter in research policy by stimulating competitive R&D networks. These new competitive network approaches changed the traditional selection process -in which public authorities fixed the broad field of research -by introducing contests: In a first stage of the funding process, participants set tasks in the framework of well defined technological areas (e.g. biotechnology, mobility in conurbation, nutrition etc.). Afterwards, independent expert jurors identify the best concepts and the most promising solutions. The winners are given the opportunity to submit detailed projects drafts and compete again. At this stage, other potential network-partners such as small and medium enterprises (SMEs) may apply to the winners for inclusion in a project. Today, we can distinguish between regional and thematic contests. Eligible for participation in these contests are industrial enterprises, scientific institutions or public sector institutions which should submit a verifiable and feasible concept for co-operation and the commercialisation of innovative ideas. The winner concepts are funded with an additional amount, but as usual companies and public institutions have to apply for individual or co-operation project grants.
Typical contests are regional co-operative contests like "BioRegio" or thematic contests like "Lead Projects" as a specific type of joint R&D pacts. Their purpose is to tackle and achieve forward looking strategic innovation goals by pooling competence in R&D to achieve marketable products, processes and services. Right from the beginning, the research process should be directed towards innovation and a collaboration between researchers and users should be created. In order to attain the given objectives, firms and universities, research institutions and users are requested to form consortia and co-operate in regional and/or thematic networks. In the nineties, R&D co-operations in technologies like ICT and Life Sciences became more significant. In context with "multi-purpose" technologies the number of firms which applied for public grants has grown substantially while the German Government faced R&D budget restrictions at the same time. Due to the conviction of positive impacts of R&D co-operations, the policy orientation changed to foster collaborations among applicants even more. Additionally, it is less expensive and more effective in terms of numbers of potential recipients to subsidize R&D networks in contrast to support single R&D projects. However, individual project funding is still high because of costly R&D projects in space technology, large scale equipment for basic research and marine technology.
Motivated by aspects of globalization another kind of policy instrument came into being in the mid 1990s: the promotion of regional networks. One reason had been that it was impossible to identify something like a German "Silicon Valley", that is a regional cluster of innovative and highly specialized firms in one technology field. Although Germany had a lot of world leading technology firms and public institutions, those are scattered all over the country. The idea of regional networks has been to push the commercialization of research and thus to create successful outstanding centers of excellence, which will be recognized by external investors in the long run. Euro (1997 Euro ( -2002 . Today, subsequent regional contests like "InnoRegio" are funded with 255
Mill. Euro and encourage people to develop their ability and discover their potential.
In summary, the German Federal Government uses two kinds of project funding to strengthen R&D activities in the economy: (a) individual project funding and (b) collaborative project funding which is more and more announced in competitions. We have to consider that there are no tax incentives for R&D in Germany, which mean that the direct project funding is currently the most important instrument of R&D policy. It is always provided for a given field of research to achieve an international high level of performance. Network contests and its competitive collaborations are a part of a recent funding philosophy. R&D policy is able to invest its budget more effectively by an increasing number of recipients and by improving its political awareness (cf. Fier/Harhoff, 2002) .
Empirical analysis of patenting behavior
Along with the scientific value and the knowledge acquired, the primary objective of German
Research is to make the most effective and efficient commercial use of R&D results. In international statistics the innovative capacity is often measured by patents (cf. OECD, 1994), for a comprehensive discussion on the use of patents as science and technology indicators). Patents play a key role in the innovation process, not only as an instrument to protect inventions but also as a source of information for the planning an implementation of R&D. Moreover patent indicators are an important measure for governments to classify their country's innovativeness in the international technology competition.
The German Federal Government stimulates the development of patent, licensing and exploitation expertise in their funding procedures. At the time, when a R&D recipient file its application, he/she already has to submit a plan for the utilization -initially in form of an outline which subsequently will become more and more detailed. All publicly funded R&D recipients are expected and encouraged to assume responsibility for their exploitation management. Wherever possible, research findings have to be commercially utilized. In order to give an incentive to the grant recipients, the Federal Government allows to keep all proceeds from the exploitation of patents for at least two years. If the recipient did not apply for a patent within two years, the R&D results become public (BMBF, 2000) .
In this section, microeconometric analyzes of firms' patenting behavior are conducted. We investigate how different firm characteristics affect the probability to file at least one patent application as well as future patent applications. Futhermore, the number of granted patents are considered. In principle we distinguish three groups of innovating companies: first, firms that did not participate in any collaborative innovation network. Second, we are able to identify firms which have not received public R&D funding but are involved in R&D co-operations. And third we consider those firms which participate in publicly funded R&D networks from the German Federal Government. If significant spillovers are produced by collaborative research activities, we hypothesize that firms participating in R&D networks will exhibit a higher propensity to patent than other enterprises. We expect, that R&D co-operations shows a higher productivity in terms of patent application due to positive spillover effects. However, it is unclear how publicly funded research networks differ from privately financed collaborations. On one hand, it may be possible that public R&D networks are less productive. It could be the case that the focus on co-operative research of modern public technology policies forces firms to collaborate in order to receive public grants. If the supply of policy schemes would had been different, those firms may well have preferred to keep their knowledge secret and conduct only research projects on their own. In this case, the publicly funded R&D networks will not benefit from spillovers as firms pursue secrecy of their research and do not interact with their research partners involved in the project. On the other hand, the publicly funded networks and the partners involved may exhibit a "higher quality" of the research carried out as the research projects have passed the governmental quality control. Non-public R&D co-operations could have failed in such a process or do only deal with less important research with respect to technological progress.
Data
In order to perform an empirical analysis as described above, we link company information from three It is noteworthy that we have excluded a few sectors (on basis of the NACE 2 three digit level) where no firm with participation in an publicly funded R&D network has been present (especially some service sectors did not include such firms). This avoids unnecessary noise in the subsequent regressions.
Empirical considerations
The dependent variable in the empirical analysis is a dummy variable PAT it indicating whether the particular firm has filed at least one patent application in recent three years. incentive, we also investigate future patent applications. The dummy LEADPAT it indicates whether firm i will file at least one patent in year t+1 or t+2. This dummy shows that a share of 28% of firms will file a patent in the next two years. This is consistent with the mean of PAT as this covers three years and LEADPAT only two. In a further extension of the analysis we also consider the number of granted patents (PGRANT it ) in section 4.4, but due to some data restrictions (the time lag between application and granting date) we start with PAT and LEADPAT only.
As described above, the focus of the exogenous variables is basically two dummy variables: from the MIP survey, we use information whether a firm has joint any collaborative R&D project in recent three years. Collaboration in this context means the active collaboration of all partners involved in the project. The mere contracting-out of R&D is definitely excluded from this definition. By combining this information with the publicly funded research consortia from the PROFI database, we are able to identify whether a firm has participated at least in one subsidized R&D co-operation or if it has only undertaken privately financed R&D co-operations in recent three years. The share of firms performing 2 NACE is the European standard sectoral classification of business activities.
collaborative research is almost 40 % which breaks down into 31 % of privately financed collaborations and 9 % of subsidized ones. We create the dummy NFCOL it for non-funded collaborations and SUBCOL it for subsidized arrangements. Additionally we include a dummy SUBSOLE it which indicates whether a firm has received grants in a non-collaborative research projects. Four percent of firms have received public grants in individual R&D projects. The inclusion of this variable prevents a bias stemming from additional funding in solely conducted research.
We use other variables to control for firm heterogeneity. Of course, we include firm size measured as the log of the number of employees LNEMP it . Since Schumpeter's seminal thoughts about innovation (see Schumpeter, 1934; Schumpeter, 1942) , it is indisputable that firm size has an impact on innovative activities, e.g. such as patenting. We also include LNEMP 2 to allow for non-(log)linearity.
Additionally to firm size, we also include firms' age as explanatory variable. On one hand, with given size very young firms may be more likely to patent because spin-offs from larger firms or research institutions typically involve innovative ideas which are then protected by intellectual property rights.
In contrast to this, older firms may show a higher likelihood to patent, because they could have undertaken continuous research which only pays-off after several years of studying and experimenting.
Moreover, the patent stock PS it is computed from the time-series of patent applications in the DPMA data by the perpetual inventory method:
where PA denotes the number of patent applications and d represents the depreciation rate of knowledge assets and is set to d = 0.15 (see e.g. Hall, 1990) . The initial value of PS in 1980 is set to zero. The bias arising from this assumption should be negligible, because the patent data are available since 1980, but the period under review in the regressions starts in 1990. The patent stock controls for the variation of the propensity to patent among firms and enters the regression as lagged value LAGPS, that is prior to the corresponding three periods of the dependent variable PAT. We divide LAGPS by the number of employees to avoid collinearity among regressors. In addition to previous patenting activities, the current potential to patent does clearly depend on the absorptive capacity of firms, i.e.
R&D inputs. We measure R&D inputs as the number of R&D employees, divide it by EMP to reduce collinearity (share of R&D employees: SRDEMP), and do also include the squared value. 72 % of firms in the sample have at least one R&D employee.
All regressions include a dummy which denotes Eastern German firms as those may behave different due to the still ongoing transformation process of the Eastern German economy. Moreover, 15 sector dummies on basis of the NACE classification should capture different technological opportunities among business sectors. In principle, these dummies are created according to the NACE two-digit sectoral classification. However, some sectors are merged due to a low number of observations. Finally, two time dummies reflects changes in patenting activities over time. See Table 1 for   descriptive statistics of the variables Table 2 for correlations. There is no collinearity among regressors except between LNAGE and LNEMP which amount to 0.37.
Older firms will naturally maintain more personnel than start-ups or younger firms entering in a phase of expansion. Moreover, EAST is negatively correlated with firms' age. This stems from the German re-unification in 1990. Most firms in Eastern Germany have been newly founded when Eastern
Germany became a market economy.
Estimation of Probit Models
We estimate Probit models on the likelihood of at least one patent application and consider a homoscedastic model and a heteroscedastic model. We performed LM tests and LR tests which show that heteroscedasticity is present (see e.g. Greene, 2000: 829-831 ). The heteroscedasticity is modeled groupwise multiplicatively with industry dummies, time dummies and firm-size dummies. However, tests have indicated that the use of industry dummies and size dummies suffice. As shown in Table 3, we find interesting results: collaborating firms (see NFCOL and SUBCOL) exhibit a significantly higher probability to file a patent than non-cooperating firms. Moreover, the coefficient of the dummy indicating subsidized co-operations is even higher than the non-funded co-operations. This may represent a hint that the subsidized collaborations often deal with key technologies which are important for future inventions and firms want to protect their property rights. Non-funded collaborations do possibly deal with less important research topics which do not as frequently generate patentable knowledge as subsidized collaborations. Note: *** (**, *) indicate a significance level of 1% (5, 10%) All estimations include 14 industry dummies and two time dummies. The heteroscedasticity is considered groupwise multiplicatively and is modeled with size and industry dummies.
The other results in Table 3 reveal the expected effects of the control variables. Larger firms are more likely to file a patent. Moreover, the stock of previous patents LAGPS is positively significant and firms with a high share of R&D employees exhibit a higher propensity to patent. However, if the share of R&D employees exceeds 60% roughly, the probability to patent decreases. There are some firms in the sample that have a higher share of R&D employees. These are usually small firms in high-tech sectors which may prefer secrecy instead of patenting, because with the patent disclosure their knowledge assets become public, at least partly. 4 Another interesting result is that firms which receive public funding for solely conducted R&D do not show a higher propensity to patent than other firms.
This does also point to the hypothesis that collaboration generates positive spillover effects. Firms which receive public funding for R&D have surely passed the "R&D quality control" of the public authorities which have granted the funds. As even such firms show less patent activities than collaborating firms, positive spillover effects seem to be present in such networks.
The regressions on future patent applications reveal the same results as the previous ones. Note that we lose the MIP wave from 2000 for these analysis, because our patent data from the DPMA does not include the years 2001 and 2002. Tests indicate that it is sufficient to include size dummies in the heteroscedasticity term. Although the coefficients between the regressions presented in Table 3 and Table 4 do slightly vary, the statements on the patenting activity remain the same. Collaborating firms, especially publicly funded ones, show a higher propensity to patent even in subsequent two years after the observed period of collaborations. Of course it would be desirable to conduct a long-term timeseries analysis, but this is not possible with the available data. Note: *** (**, *) indicate a significance level of 1% (5, 10%) All estimations include 14 industry dummies and one time dummy. The heteroscedasticity is considered groupwise multiplicatively and is modeled with size dummies.
As a test on the robustness of the findings above, we consider the same regressions for a subsample small and medium-sized firms (SMEs) with less than 250 employees. Table 5 and Table 6 show that the results do not change much. Again, tests indicated that it is sufficient to include size dummies in the heteroscedasticity term. Note: *** (**, *) indicate a significance level of 1% (5, 10%) All estimations include 14 industry dummies and two time dummies. The heteroscedasticity is considered groupwise multiplicatively and is modeled with size dummies.
The impact of the mere firm size vanishes, but the share of R&D employees and the magnitude of the stock of previous patents remain highly significant. The coefficients of collaborations as focus of the analysis are still significantly different from zero. However, the non-funded collaborations are insignificant in the regression on future patent activities. Even for SMEs, the spillovers generated in publicly funded R&D networks seem to be larger than in other co-operative research. Note: *** (**, *) indicate a significance level of 1% (5, 10%) All estimations include 14 industry dummies and one time dummy. The heteroscedasticity is considered groupwise multiplicatively and is modeled with size dummies.
Extension of the analysis on counts of granted patents
As final variable of interest we use not only a dummy on patent applications, but count the requests.
However, the quality or economic value of patent applications may vary among firms. One possibility to improve the mere patent counts as a measure for valuable knowledge is to weight the applications with their citations (see Hall et al. 2001 , for example). Unfortunately this is not possible with our data as long time series after the patent disclosure would be needed to count (or estimate) the future citations. Hence, we can only use the information on granted patents. We time the patent by its application date to avoid time lags between the undertaken research and the output indicator, but count just those applications which will be granted in the future as valuable research results. Due to the time lag between application and granting date (in the 1980s and early 1990s, for example, on average between 4 to 5 years depending on the year of application), we drop our MIP data from the year 2000 and use only the observations from 1992 and 1996.
In contrast to the U.S. where the majority of patent requests become granted patents usually, the ratio of applications to granted patents is different in Germany: For example, in 1996 (1992) only 44%
(70%) of all patent applications were granted until 2000. Still we have to assume that patent applications which are not granted until 2000 have not been succesful. This leads to a downward bias for the year 1996 as there may well be applications that will be granted after four years. Therefore this analysis should be interpreted carefully.
In view of this data, a count data model on the number of granted patents is estimated. We employ a Negative Binomial regression (see e.g. Greene, 2000, 886-887) instead of a Poisson model, because a likehood ratio test indicated that the hypothesis on no overdispersion has to be rejected.
The results of the previously estimated Probit models are confirmed by the regression on the number of granted patents (see Table 7 ). Collaborating firms which did not participate in publicly funded R&D consortia have more granted patents than non-collaborating firms on average. Furthermore, the members of publicly supported R&D networks reveive even higher numbers of granted patents than other collaborating firms. Again, the results point to positive spill-over effects of collaboration. Note: *** (**, *) indicate a significance level of 1% (5, 10%) The estimation includes 14 industry dummies and one time dummy.
Although the previous results turn out to be quite stable in different settings, it is possible that the regressions are subject to a self-selection bias. Subsidized firms may substantially be different from other firms that a self selection into subsidized networks occurs. Moreover, the government follows a "pick-the-winner" strategy. The same may be true for collaborations in general. Firms will also apply "picking the winner" when searching for appropriate partners for joint R&D activities. It is therefore questionable if such firms were less likely to apply for a patent if they had not participated in a publicly funded R&D network. For this reason, we apply a non-parametric matching procedure in the following subsection which is able to account for selectivity.
Estimation of Treatment Models

Matching and Identification
The matching approach has been developed to identify treatment effects when the available observations on individuals or firms are subject to a selection bias. This typically occurs when participants in public measures differ from non-participants in important characteristics, for example (see Heckman et al., 1999; Heckman et al., 1997 for surveys) . Popular economic studies are on the benefit of active labor market policies.
The matching is able to address directly the question "What would a treated firm with given characteristics have done if it had not been treated?" A treatment in our context is the participation in an R&D network. We distinguish collaborating and non-collaborating firms as well as subsidized and ( ) ( ) ( )
where YT is the outcome variable, that is the propensity to patent in our case. The status S refers to the group: S=1 is the treatment group and S=0 the non-treated firms. YC is the potential outcome which had been realized if the treatment group (S=1) had not been treated. The problem is obvious: while the outcome of the treated individuals in case of treatment, E(YT|S=1), is directly observable, it is not the case for the counterpart. What would these firms have realized if they had not received the treatment?
E(YC|S=1) is a counterfactual situation which is not observable and, therefore, has to be estimated. In the case of matching, this potential outcome is constructed from a control group of non-participants.
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The matching relies on the intuitively attracting idea to balance the sample of program participants and comparable non-participants. Remaining differences in the outcome variable between both groups are then attributed to the treatment (Heckman et al., 1997) .
Initially the counterfactual cannot simply be estimated as average outcome of the non-participants, because E(YC|S=1) ¹ E(YC|S=0) due to the possible selection bias. The participant group and nonparticipant group are expected to differ, except in cases of randomly assigned measures in experimental settings. Rubin (1977) introduced the conditional independence assumption (CIA) to overcome the selection problem, that is, participation and potential outcome are independent for individuals with the same set of exogenous characteristics X. If this assumption is valid, it follows that
The outcome of the non-participants can be used to estimate the counterfactual outcome of the participants in case of non-participation provided that there are no systematic differences between both groups. The treatment effect can be written as
Conditioning on X takes account of the selection bias due to observable differences between participants and non-participants.
Estimation of the counterfactual
A weight w ij is defined with respect to X for each participant i which assignes a high weight to nonparticipants j being similar in X and vice versa. The weights w ij sum up to one. The treatment effect for participant i is
The outcome of the treated individual i is compared to the outcome of non-treatment of all nonparticipants j. According to Heckman et al. (1997) matching estimators differ with respect to the weights attached to members of the comparison group. The extreme cases are to use all non-treated individuals as control group or to pick just the most similar control observation. The latter case is called nearest neighbor matching. The weight would be equal to one for the most similar control observation and would be zero for all other cases. Nearest neighbor matching has already been applied in industrial economic literature to estimate the impact of R&D subsidies on R&D investment at the firm level (see Czarnitzki, 2001; Czarnitzki/Fier, 2002; Almus/Czarnitzki, 2003) .
In this study, a kernel-based matching is applied. In contrast to the nearest neighbor matching where only one control observation is assigned to each participant, the entire group of non-participants is used for every participating firm. Therefore, a non-parametric regression in the sample of nonparticipants is performed to determine the weights for the potential non-treatment outcome. The weights are specified as
The kernel K downweights observations with respect to their distance to X i . h is the bandwidth parameter. The weights are obtained by a non-parametric regression that is a locally weighted average of the outcome of the non-treated firms with similar characteristics. In this case, the Nadaraya-Watson kernel regression is applied. The minimization problem to obtain the non-treatment estimate for i is (see Pagan and Ullah, 1999, section 3.2) ( )
The resulting estimator equals
As one often wants to consider more than one matching criterion, one has to deal with the "curse of dimensionality". If we employ a lot of variables in the matching function, it will become difficult to find appropriate controls. Rosenbaum/Rubin (1983) suggested to use a propensity score as a single index and thus to reduce the number of variables included in the matching function to just one. Therefore a probit model is estimated on the collaboration dummy. The estimated propensity scores are subsequently used as matching criterion. Lechner (1998) introduced a modification of the propensity score matching as one often wants to include additional variables, e.g. like firm size, directly in the matching function. In this case, instead of a single X (propensity score), other characteristics of the individuals may be employed in the matching function. Therefore the
is used as argument in the kernel function. W is the empirical covariance matrix of the vector X j .
Finally, the kernel function and the bandwidth have to be chosen. We use the Gaussian kernel ( )
and the bandwith h is chosen according to Silverman's (1986) rule of thumb as ( )
where k is the number of variables included in X, n is the number of observations and ( ) min , /1.34 A s iqr = with s as the standard deviation and iqr as the inter-quartile range of X in the sample of non-participants (see also Bergemann et al., 2001 ).
The Nadaraya-Watson kernel regression is performed for every participant in the sample, that is, an estimate of the potential outcome for each i is constructed from the entire sample of non-treated firms.
Once the samples have been balanced by the kernel matching procedure, remaining differences in the outcomes are not due to previous heterogeneity in observable characteristics, but can be assigned to the treatment if no selection on unobservables occurs.
Empirical application of the kernel-based matching
We perform two applications of the matching estimator. First, we investigate whether collaborating firms are still more likely to apply for a patent than non-collaborating firms when we consider a possible selection bias. Second, we analyze the group of collaborating firms only, in order to study if the collaborating firms which are publicly subsidized do still show a higher probability to patent than firms which only participate in not publicly funded collaborations.
As the matching relies on the idea of comparing similar observations, we decided to restrict the sample to companies with 5,000 employees at most, because it is not very meaningful to look for similar firms when they are larger than this threshold. Such huge companies are unique in the German economy.
We consider a propensity score matching without other variables in the matching function, and estimate a Probit model on the collaboration dummy with these explanatory variables: LNEMP, its squared values, LAGPS/EMP, SRDEMP and its squared values, EAST, LNAGE as well as 14 industry and two time dummies. The observations of the matched control group are required to belong to the same year of observation as the participant. Therefore the weights w ij of potential controls from other years are set to zero during the matching procedure. Table 8 shows the mean values of the considered characteristics of the different firm groups: collaborating firms as "treatment group" and non-collaborating firms as control group. We have 1,564 cooperating firms and 2,473 non-cooperating firms. As the t-tests indicate those firm groups differ significantly in size, in the share of R&D employees, the patent stock and age. Moreover, the sectoral distribution is different (not presented in Table 8 ). Most important, the groups exhibit different propensity scores on collaboration. As the right column in Table 8 shows, the matching is successful.
After the estimation of the control group all differences in exogenous characteristics vanish. However, the patent dummies PAT, LEADPAT and PGRANT do still differ among groups. Despite controlling for a possible selection bias, collaborating firms are more likely to patent than others, that is we can attribute this circumstance to the fact of collaboration which again supports the hypothesis that positive spillover effects are generated in R&D networks. Notes: § Only 1,145 observations on collaborating firms and 2,107 on the potential control group (from the years 1992 and 1996) *** (**, *) indicate a significance level of 1% (5, 10%) in a two-tailed t-test on equal means of the corresponding group and the collaborating firms. Mean differences of sectors are not presented. However, the distribution over industries differs prior to the matching but vanishes after the estimation of the control group.
Our second matching approach considers only collaborating firms and we distinguish publicly funded and non-funded co-operations. Note that this comparison among collaborating firms even rules out differences in patenting behavior among firms which is due strategic reasons when firms enter cooperations. As all firms under consideration co-operate, we can assign possible differences to the fact of the subsidization and not only to strategic patenting behavior which may be typical for to collaborations.
Our sample contains 356 subsidized firms compared to 1,208 firms which did collaborate but did not receive public grants for this. The matching functions includes not only the propensity score but also the firm sie (EMP). As Table 9 shows, the groups do again differ prior to the matching, but the differences in explanatory variables vanish after the matching. Once again, the differences in the likelihood to patent (PAT and LEADPAT) and the granted patents (PGRANT) remain significantly. Note: § Only 174 observations on subsidized collaborating firms and 971 on the potential control group (from the years 1992 and 1996) *** (**, *) indicate a significance level of 1% (5, 10%) in a two-tailed t-test on mean differences between the corresponding group and the collaborating firms. Mean differences of sectors are not presented. However, the distribution over industries differs prior to the matching but vanishes after the estimation of the control group.
This evidence points to the fact that R&D collaborations do not only generate spillovers in general, but does also show that there are differences between publicly funded networks and purely privately financed ones. On one hand, it may be more difficult to keep the knowledge produced secret in subsidized networks, because the title and content of the research proposals is available to the public.
Therefore, firms will seek to establish their property rights by patent protection immediately. On the other hand, it may be the case that recipients of public grants want to declare that the public investment has led to successful results. First, recipients will almost surely apply for future grants and with prior success they can prove their eligibility. Second recipient firm are forced to patent by the legal framework in the Federal Government's funding conditions (not utilized research results will become a public good two years after completion of the research).
Conclusions
When Europe decided to catch up with the technological leadership of the USA, Germany introduced the direct project funding to strengthen the technological competitiveness of nationals' industry. While former project funding was offered as an individual firm's R&D grant, researchers and policy makers realised the benefits of R&D co-operations in the 1980s. In the same time the German Government was criticised because of a subjective allocation of public R&D grants to large firms and because of incurring market distortions. In the mid eighties the German Federal Government added the collaborative R&D funding and switched its funding philosophy for the first time. We do observe impressively an increasing number of collaborative projects, especially in applied technological fields.
In the early nineties the R&D funding procedures changed for a second time. Germany opened a further chapter in research policy by stimulating competitive R&D networks. The usual criticised awarding of public funds by Governments' authorities, even in individual R&D projects either in collaborative R&D projects, was added by "contests". In these contests firms and universities, research institutions and users were asked to form R&D networks and to compete among different R&D cooperations and collaborative R&D concepts. Today, the funding of R&D collaboration is an essential element of German Governments R&D funding and most important, because Germany did not offer any R&D tax credits. Our study has focused on the return of investment on that R&D policy shift by analysing the benefits of public incentives for R&D collaborations in terms of innovative output.
In a first step, we investigate the benefits of public incentives for R&D collaborations in terms of patents in a microeconometric analysis. We distinguish companies which have been publicly funded in R&D co-operations in comparison to non-funded firms. Our hypothesis is in line with the literature on collaborative research, that spillovers are generated within R&D co-operations. In difference to other empirical studies we use a huge database and distinguish publicly funded R&D co-operations and nonfunded co-operations. Comparing these two groups, we find evidence that there are differences between publicly funded networks and purely privately financed ones. We have shown, that firms in publicly funded networks are more likely to apply for a patent than firms in private networks. These findings are supported by Probit regressions on a patent dummy and a dummy for future applications as well as a count data model on the number of granted patents. Moreover, the results do even hold in econometric models which take account of a possible selection bias. We apply a kernel-based matching and compare collaborating and non-collaborating firms as well as collaborating companies which received public grants and firms that did finance R&D cooperation's privately.
The interpretation of our results is twofold: On one hand, it may be more difficult to keep know-how in subsidized networks even secret, because the output is available to all network partners which is synonymous to a public good. In this case, firms seek to establish their property rights by patent protection immediately. On the other hand, it may be the case that recipients of public grants apply their successful result as a patent, to impress their sponsor (Federal Government) as much as their shareholders, competitors etc. Herein recipients of R&D funds take future applications for R&D grants into account and patenting might be a good strategy to convince funding authorities prior to the next application. A third interpretation my result from official requirements: Although patenting or licensing is not conditional, recipient firms are forced to patent by Federal Government's funding conditions.
Finally, it would be useful to distinguish between private-private and public-private partnerships in future research to get more knowledge about the origins of know-how, its transformation into products and processes and thus the efficiency of publicly funded R&D networks. An extension of our analysis on patent counts weighted with their future citations would be desirable in order to control for the heterogeneity among patents in terms of their economic value.
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